Table 2. Serum levels of osteoprotegerin in the three groups studied: 49 prostate cancer patients with confirmed skeletal metastases, 82 patients with localized prostate cancer and 41 healthy male controls. Data expressed as median values.

n: number, #: statistically significant difference between metastatic prostate cancer patients and patients without bone metastases or healthy controls